Trials / Completed
CompletedNCT03049514
Study of Arterial Recanalization of the Central Retinal Artery Occlusions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Central retinal artery occlusions (CRAO) are the equivalent of an ischemic stroke (IS) at the retinal level. They share the same risk factors and common pathology. Their incidence is lower (8.5 / 100,000) and the functional prognosis is unfavorable in 80% of cases with visual acuity (VA) \<1/10. The diagnosis of an CRAO is clinically based on the sudden occurrence of a decrease in deep visual acuity with fundamentally signs of reactive ischemia. There is no data on early retinal arterial recanalization after CRAO, nor on the relationship between early recanalization (spontaneous or post-thrombolysis) and visual prognosis.
Conditions
Timeline
- Start date
- 2016-12-23
- Primary completion
- 2022-04-02
- Completion
- 2022-04-02
- First posted
- 2017-02-10
- Last updated
- 2022-04-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03049514. Inclusion in this directory is not an endorsement.